The central dopaminergic system and depression;Das zentrale dopaminerge System und die Depression

Nervenarzt

Volumn 68, Issue 7, 1997, Pages 545-555

  Ebert, D ^a   Lammers, C H ^b,c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

antidepressants; depression; dopamine; neurobiology; neuroimaging

Indexed keywords

AMINEPTINE; ANTIDEPRESSANT AGENT; LEVODOPA; ROXINDOLE; SELEGILINE;

DEPRESSION; DOPAMINERGIC SYSTEM; HUMAN; REVIEW;

ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN MAPPING; DEPRESSIVE DISORDER; DOPAMINE; HUMANS; LIMBIC SYSTEM; MESENCEPHALON; RECEPTORS, DOPAMINE;

EID: 0030751562     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001150050159     Document Type: Review

References (89)

1. Alexander G (1986) Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Ann Rev Neurosci 9:357-381
2. Ansseau M (1992) Diagnostic and therapeutic usefulness of biological markers of depression. University Press, Liege
3. Ayd F, Zohar J (1987) Psychostimulant therapy for chronic and treatment-resistant depression. In: Zohar, Belmaker (eds) Treating resistent depression. PMA, New York, pp 343-355
4. Belmaker R, Wald D (1977) Haloperidol in normals. Br J Psychiatry 131:222-223
5. Benkert O, Brunder G, Wetzel H (1992) Dopamine autoreceptor agonists in the treatment of schizophrenia and depression. Pharmacopsychiatry 25:254-260
6. Borsini F, Meli A (1990) The forced swimming test: its contribution to the understanding of the mechanisms of action of antidepressants. In: Borsini, Meli (eds) Dopamine and mental depression. Pergamon Press, Oxford, pp 63-76
7. 2 receptor mRNA. Brain Res 564:203-219
8. Chiodo L, Antelman S (1980) Repeated tricyclics induce a progressive dopamine autoreptor subsensivity independent of daily drug treatment. Nature 287 451-454
9. Csernansky J, Newcomer J (1995) Maintenance drug treatment for schizophrenia. In: Bloom F, Kupfer D (eds) Psychopharmacology Raven, New York, pp 1267-1275
10. Cummings J (1985) Psychosomatic aspects of movement disorders. Adv Psychosom Med 13:111-132
11. Depue R, Arbisi P, Krauss S, Iacono W, Leon A, Muir R, Allen J (1990) Seasonal independence of low prolactin concentration and high spontaneous eye blink rates in unipolar and bipolar II seasonal affective disorder. Arch Gen Psychiatry 47:356-364
12. 3 receptors on neurotensin mRNA expression in nucleus accumbens. Eur J Neurosci 6:1384-1387
13. 3 receptor in the rat brain. Neurosci 65:731-745
14. Diggory G, Buchett W (1984) Chronic antidepressant administration fails to attenuate apomorphine-induced decreases in rat striatal dopamine metabolites. Eur J Pharmacol 105:257-263
15. D'haenen H, Bossuyt A (1994) Dopamine D2 receptors in depression measured with SPECT. Biol Psychiatry 35:128-132
16. Ebert D, Feistel H, Barocka A (1991) Effects of sleep deprivation on the limbic system and the frontal lobes in affective disorders: a study with Tc99m HMPAO SPECT. Psychiatry Res Neuroimaging 40:247-251
17. Ebert D (1992) Alterations of drive in differential diagnosis of mild affective disorder. Psychopathology 25:23-28
18. Ebert D, Kaschka W, Stegbauer P, Schrell U (1993) Prolactin response to sulpiride in depression before and after sleep deprivation. Biol Psychiatry 35:880-885
19. Ebert D, Feistel H, Barocka A, Kaschka W (1994a) Increased limbic blood flow and total sleep deprivation in major depression with melancholia. Psychiatry Res Neuroimaging 55:101-109
20. 2 receptor blockade in depression before and after sleep deprivation. Biol Psychiatry 35:880-885
21. Ebert D, Kaschka W (1995) Humorale Aspekte des Schlafentzuges. Fortschr Neurol Psychiatr 63:441-450
22. 2 receptor SPECT before and after antidepressant therapy. Psychopharmacology 126:91-94
23. Ebert D, Ebmeier K (1996) The role of the cingulate in depression - from functional neuroanatomy to neurochemistry. Biol Psychiatry 39:1044-1050
24. Ebert D, Albert R, Hammon G, Strasser S, May A, Merz A (1996) Eye blink rate and depression - is the antidepressant effect of sleep deprivation mediated by the dopamine system? Neuropsychopharmacology 15.332-339
25. Ehrensing R, Kastin A, Wurzlow G, Michell G, Mebane A (1994) Improvement in major depression after low subcutaneous doses of MIF-1. J Affect Disord 31:227-233
26. Fibiger H, Phillips A (1981) Increased intracranial self-stimulation in rats after long-term administration of desipramine. Science 214:683-685
27. Fibiger H (1995) Neurobiology of depression: focus on dopamine. In: Gessa G, Fratta W, Pani L, Serra G (eds) Depression and mania: from neurobiology to treatment Raven, New York, pp 1-17
28. Flint A, Black S, Taylor I, Gailey G, Levinton C (1994) Abnormal speech articulation, psychomotor retardation, and subcortical dysfunction in major depression. J Psychiatry Res 27 309-319
29. Fochtmann L, Cruciani R, Aiso M, Potter W (1989) Chronic electroconvulsive shock increases D-1 receptor binding in rat substantia nigra. EurJ Pharmacol 167:305-306
30. 1 dopamine receptor mRNA in brain supports a role in cognitive, affective, and neuroendocrine aspects of dopaminergic neurotransmission. Proc Natl Acad Sci 88:3772-3776
31. Gessa G, Pani L, Serra G, Fratta W (1995) Animal models of mania. In: Gessa G, Fratta W, Pani L, Serra G (eds) Depression and mania: from neurobiology to treatment. Raven, New York, pp 43-66
32. Goodwin F, Ebert M, Bunney W (1972) Mental effects of reserpine in man:a review. In: Shader F (ed) Psychiatric complications of medical drugs. Raven, New York, pp 73-101
33. Goodwin F, Popst R, Dunner D, Gordon E (1973) Cerebrospinal fluid amine metabolites in affective illness. The probenecid techniques. Am J Psychiatry 130:73-79
34. Hall H, Wedel I, Halldin C, Kopp J, Farde L (1990) Comparison of the in vitro receptor binding properties of N3H-methylspiperone and 3H-reclopride to rat and human brain membranes. J Neurochem 55:2048-2057
35. Heimer L, Zahm D, Churchill L, Kalivas P, Wohltmann C (1991) Specificity in the projection patterns of accumbal core and shell in the rat. Neurosci 41:89-125
36. Jimerson D (1987) Role of dopaminergic mechanisms in the affective disorders. In: Meltzer H (ed) Psychopharmacology:the third generation of progress. Raven, New York, pp 505-511
37. Kapur S, Mann J (1992) Role of the dopaminergic system in depression. Biol Psychiatry 32:1-17
38. Kinney J (1985) Nomifensine maleate:a new second generation antidepressant. Clin Phar 4.625-636
39. Lammers C-H, Diaz G, Lévesque D, Griffon N, Schwartz J-C, Sokoloff P (1995) Regulation of dopaminergic receptor mRNA by antidepressants. Pharmacopsychiatry 28:196
40. 3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons. Proc Natl Acad Sci 92:1719-1723
41. Liebmann J, Cooper S (1989) The neuropharmacological basis of reward. Clarendon, Oxford
42. Logan J, Dewey S, Wolf A, Fowler J, Brodie J, Angrist B, Volkow N, Gatley J (1991) Effects of endogenous dopamine on measures of 18N-methyl-spiperone binding in the basal ganglia. Synapse 9:195-207
43. Mai J (1990) Behavioral effects of antidepressant drugs given repeatedly on the dopaminergic system. In. Gessa G, Serra G (eds) Dopamine and mental depression. Pergamon, Oxford, pp 139-146
44. Marsden C (1991) The neuropharmacology of serotonin in the central nervous system. In: Feighner J, Boyer W (eds) Selective serotonin reuptake inhibitors. Wiley, Chichester, pp 11-36
45. Matussek N, Ackenheil M, Athen D, Beckmann H, Benkert O, Dittmer T, Hippius H, Loosen P, Rüther E, Scheller M (1974) Catecholamine metabolism under sleep deprivation therapy of improved an not-improved depressed patients. Pharmacopsychiatry 7:108-114
46. Mayeux R (1991) Parkinson's disease. J Clin Psychiatry 51:20-23
47. 2 receptor mRNA in rat brain. Proc Natl Acad Sci USA 86.7652-7628
48. Meador-Woodruff J (1994) Update on dopamine receptors. Ann Clin Psychiatry 6:79-90
49. Mendis N, Hanwella D, Weerasinghe C, Illesinghe C, DeSilva D (1989) A double-blind comparative study: amineptine versus imipramine. Clin Neuropharmacol 12:58-65
50. Muscat R, Papp M, Willner P (1994) Reversal of stress-induced anhedonia by the atypical antidepressants, fluoxetine and maprotiline. Psychopharmatology 109:433-438
51. Nielsen J (1986) Effects of chronic antidepressant treatment on nigrostriatal and mesolimbic dopamine autoreceptors in the rat. Neurochem Int 9:61-67
52. Nomikos G, Damsa G, Wenkstern D, Fibiger H (1991) Chronic desipramine enhances amphetamine-induced increases in interstitial concentrations of dopamine in the nucleus accumbens. Eur J Pharmacol 195:63-73
53. Nutt D, Glue P (1993) The neurobiology of ECT: Animal studies. In. Coffey E (ed) The clinical science of electroconvulsive theray. APP,Washington, pp 213-234
54. Papez J (1937) A proposed mechanism of emotion. Arch Neurol Psychiatry 38.725-743
55. Papp M, Muscat R, Willner P (1993) Subsensitivity to rewarding and locomotor stimulant effects of a dopamine agonist following chronic mild stress. Psychopharmacology 110.152-158
56. 2 receptor binding in limbic forebrain associated with chronic mild stress-induced anhedonia and its reversal by imipramine. Psychopharmacology 112:110-114
57. Parker G, Hazdi D, Wilhelm K, Hickie I, Brodaty H, Boyce P, Mitchell P, Eyers K (1994) Defining melancholia: properties of a refined signbased measure. Br J Psychiatry 164 316-326
58. Pearlson G, Schlaepfer T (1995) Brain imaging in mood disorders. In: Bloom F, Kupfer D (eds) Psychopharmacology. Raven, New York, pp 1019-1028
59. 2 receptor density in psychotic and nonpsychoatic patients with bipolar disorder. Arch Gen Psychiatry 52.471-477
60. Post R, Kotin J, Goodwin F, Gordon E (1973) Psychomotor activity and cerebrospinal fluid amine metabolites in affective illness. Am J Psychiatry 130.67-72
61. Post R, Gerner R, Carman J (1978) Effects of dopamine agonist peripedil in depressed patients. Arch Gen Phsychiatry 35:509-615
62. Rampello L, Nicoletti G, Raffaele R (1991) Dopaminergic hypothesis for retarded depression: a symptom pofile for predicting therapeutical response. Acta Psychiatr Scand 84:552-554
63. Randrup A, Munkvad I, Fog R (1975) Mania, depression and brain dopamine. In. Essman E, Valzelli A (eds) Current developments in psychopharmacology. Spectrum, New York, pp 207-229
64. Roy A, Karoum F, Pollack S (1992) Marked reduction in indexes of dopamine metabolism among patients with depression who attempt suicide. Arch Gen Psychiatry 49:447-450
65. Sachdev P, Aniss A (1993) Slowness of movement in melancholic depression. Biol Psychiatry 35:253-262
66. Sackheim H, Devanand D, Nobler M (1995) Electroconvulsivetherapy. In: Bloom F, Kupfer D (eds) Psychopharmacology. Raven, New York, pp 1123-1141
67. Schultz W, Apicella P, Ljungberg T (1993) Responses of monkey dopamine neurons to reward and conditioned stimuli during successive steps of learning a delayed response task. J Neurosci 13.900-913
68. Schwartz J-C, Giros B, Martres M-P, Sokoloff P (1992) The dopamine receptor family: molecular biology and pharmacology. Semin Neurosci 4:99-108
69. Serra G, Argiolas A, Klimek V, Fadda F, Gessa G (1979) Chronic treatment with antidepressants prevents the inhibitory effect of small doses of apomorphine on dopamine synthesis and motor activity. Life Sci 25.415-424
70. Settle E (1989) Bupropion. A novel antidepressant-Update 1989. Int Drug Ther Newslett 24:449-454
71. Silverstone T (1985) Dopamine in manic depressive illness. J Affect Disord 8:225-231
72. Siris S (1991) Diagnosis of secondary depression in schizophrenia: Implications for DSM-IV. Schizophr Bull 17 75-98
73. Sokoloff P, Schwartz J-C (1995) Novel dopamine receptors half a decade later. TiPS 16.270-275
74. Sokolski K, Reist C, Chen C, DeMet E (1995) Antidepressant responses and changes in visual adaption after sleep deprivation. Psychiatry Res 57.197-207
75. Standish-Berry H, Bouras N, Bridges P, Watson J (1983) A randomised double blind group comparative study of sulpiride and amitriptyline in affective disorders. Psychopharmacology 81:258-260
76. Stotz G, Angst J, Woggon B (1996) Einsatz von Psychostimulantien (Amphetamin und Methylphenidat/Ritalin) bei therapiere-fraktären Depressionen (unveroffentliches Manuskript)
77. Van Praag H, Korf J (1971) Retarded depression and the dopamine metabolism. Psychopharmacologia 19:199-203
78. Van Praag H, Korf J, Lakke J, Schut T (1975) Dopamine metabolism in depressions psychoses, and Parkinson's diseases: the problem of the specifity of biological variables in behavior disorders. Psychol Med 5:138-146
79. Vestergaard P, Sorensen T, Hoppe E, Rafaelsen O, Yates C, Nicolaou N (1978) Biogenic amine metabolites in cerebrospinal fluid of patients with affective disorder. Acta Psychiatr Scand 58:88-96
80. Volk S, Kaendler S, Weber R, Georgi K, Maul F, Bertel A, Pflug B (1992) Evaluation of the effects of total sleep deprivation on cerebral blood flow using single photon emission computerized tomography. Acta Psychiatr Scand 86:478-483
81. Warneke L (1990) Psychostimulants in psychiatry. Can J Psychiatry 35:3-10
82. Wells B, Marken P (1989) Bromocriptine in the treatment of depression. DICP 23:601-602
83. Willner P (1983) Dopamine and depression: A review of recent evidence. Brain Res Rev 6:211-236
84. Willner P, Muscat R, Papp M (1992) Chronic mild stress-induced anhedonia: a realistic model of depression. Neurosci Biobehav Rev 16:525-534
85. Willner P, Lappas SSC, Muscat R (1994) Reversal of stress-induced anhedonia by the dopamine receptor agonist, pramipexole. Psychopharmacology 115:454-462
86. Willner P (1995) Dopaminergic mechanisms in depression and mania. In. Bloom F, Kupfer D (eds) Psychopharmacology. Raven, New York, pp 921-932
87. Wu J, Gillin J, Buchsbaum M, Hershey T, Johnsin J, Bunney W (1992) Effects of total sleep deprivation on brain metabolism of depressed patients. Am J Psychiatry 149:538-543
88. Wu J, Gillin J, Buchsbaum M, Cadwell S, Lottenberg S, Bunney W (1994) PET studies of sleep deprivation in unipolar depression. Neuropsychopharmacology 10:876
89. Zahm D, Brog J (1992) On the significance of subterritories in the"accmbens" part of the rat ventral striatum. Neuroscience 50:751-767